Table 2. Summary statistics of the top 20 KEGG integrated pathways ranked by the ratio between no. of miRNAs and no. of genes.
Pathway name | No. of genes | No. of miRNAs + genes | |
---|---|---|---|
Bladder cancer | 29 | 127 | 4.3 |
Viral carcinogenesis | 6 | 26 | 4.3 |
Dorso-ventral axis formation | 12 | 42 | 3.5 |
Rheumatoid arthritis | 19 | 65 | 3.4 |
Malaria | 11 | 35 | 3.1 |
Glioma | 65 | 189 | 2.9 |
Thyroid cancer | 28 | 80 | 2.8 |
Melanoma | 69 | 196 | 2.8 |
Colorectal cancer | 49 | 138 | 2.8 |
Chronic myeloid leukemia | 73 | 204 | 2.7 |
Endometrial cancer | 45 | 124 | 2.7 |
Pancreatic cancer | 69 | 189 | 2.7 |
p53 signaling pathway | 68 | 181 | 2.6 |
Non-small cell lung cancer | 52 | 138 | 2.6 |
Prostate cancer | 87 | 230 | 2.6 |
Renal cell carcinoma | 60 | 145 | 2.4 |
Acute myeloid leukemia | 57 | 133 | 2.3 |
ErbB signaling pathway | 88 | 197 | 2.2 |
Small cell lung cancer | 83 | 181 | 2.1 |
VEGF signaling pathway | 67 | 146 | 2.1 |